Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy.
Saved in:
| Title: | Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy. |
|---|---|
| Authors: | Battistini, Elisa1 (AUTHOR), Lapuhs, Philipp1 (AUTHOR), Jiménez, Alberto1,2 (AUTHOR), Garrido-Areal, Sergio1 (AUTHOR), Rivas-Gómez, Lucía3 (AUTHOR), Zagorac, Ivana3 (AUTHOR), Álvarez-Vallina, Luis3,4 (AUTHOR), Alonso, María José1,5 (AUTHOR), Sanjurjo, Lucía6 (AUTHOR) lucia.sanjurjo.bouza@sergas.es |
| Source: | Molecular Cancer. 11/17/2025, Vol. 24 Issue 1, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14764598 |
|---|---|
| DOI: | 10.1186/s12943-025-02501-9 |